IP Library Granted Patent US 7,842,489
Granted Patent B2
US 7,842,489 · App. 12/710,969 · Granted Nov 30, 2010

Use of meganucleases for inducing homologous recombination ex vivo and in toto in vertebrate somatic tissues and application thereof

Assignee: Cellectis
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,842,489
App. No.
12/710,969
Granted
Nov 30, 2010
Kind
B2
Abstract

A single chain homing endonuclease, comprising a first variant of I-CreI having the amino acid sequence of accession number pdb 1g9y (SEQ ID NO: 23 is residues 1-153 of pdb Ig9y) and a second variant of I-CreI variant having the amino acid sequence of accession number pdb 1g9y (SEQ ID NO: 23 is residues 1-153 of pdb Ig9y) in a single polypeptide.

Claims (7)

1. A single chain homing endonuclease, comprising a first variant of I-CreI having the amino acid sequence of SEQ ID NO:23 and a second variant of I-CreI having the amino acid sequence of SEQ ID NO:23 in a single polypeptide, wherein said first variant of I-CreI contains the following substitutions: one to six substitutions in the sequence of amino acid residues 26 to 40 and two to three substitutions in the sequence of amino acid residues 44 to 77, wherein in said first variant of I-CreI there is a substitution at positions 33, 68 and 77, and independently, said second variant of I-CreI contains the following substitutions: four to six substitutions in the sequence of amino acid residues 26 to 40 and two to three substitutions in the sequence of amino acid residues 44 to 77, wherein in said second variant of I-CreI there is a substitution at positions 26, 30, 32, 38, 44, and 68, wherein the endonuclease binds and cleaves DNA.

2. The single chain homing endonuclease according to claim 1 , wherein said second variant of I-CreI further contains a substitution at positions 40 and 77.

3. The single chain homing endonuclease according to claim 1 , wherein said first variant of I-CreI has a substitution at least at positions 24, 33, 68, and 77, and in said second variant of I-CreI has a substitution at least at positions 26, 30, 32, 38, 40, 42, 44, 68, and 77.

4. The single chain homing endonuclease according to claim 1 , wherein said first variant of I-CreI further contains a substitution at position 140.

5. The single chain homing endonuclease of claim 1 wherein the DNA sequence has at least 25% identity with the I-CreI recognition and cleavage site of SEQ ID NO:10.

6. The single chain homing endonuclease of claim 5 wherein the DNA sequence has at least 50% identity with the I-CreI recognition and cleavage site of SEQ ID NO:10.

7. The single chain homing endonuclease of claim 6 wherein the DNA sequence has at least 75% identity, with the I-CreI recognition and cleavage site of SEQ ID NO:10.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 1, 2010
From: ARNOULD, SYLVAIN; BRUNEAU, SYLVIA; CABANIOLS, JEAN-PIERRE; CHAMES, PATRICK; CHOULIKA, ANDRE; DUCHATEAU, PHILIPPE; EPINAT, JEAN-CHARLES; GOUBLE, AGNES; LACROIX, EMMANUEL; PAQUES, FREDERIC; PEREZ-MICHAUT, CHRISTOPHE; SMITH, JULIANNE; SOURDIVE, DAVID
To: CELLECTIS
Reel/Frame 025228/0484 →
Continuity (4)
Continuation 1054355700
Provisional Application 6044291100 · Jan 28, 2003
Provisional Application 6049153500 · Aug 1, 2003
Related Publication 20100144012A1 · Jun 10, 2010